Queensland University of Technology   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Brisbane Australia (1989)

Organization Overview

First Clinical Trial
2012
NCT01686126
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Eman Mohamed othman | Queensland University of Technology | Queensland University of Technology (QUT) Institute of Health and Biomedical Innovation (IHBI)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Carcinoma, Endometrioid (Phase 2)

Cognitive Dysfunction (Phase 2)

Endometrial Hyperplasia (Phase 2)

Hyperplasia (Phase 2)

Myositis Ossificans (Phase 2)

Parkinson Disease (Phase 2)

Pneumonia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 11